Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 29;90(10):4905-4913.
doi: 10.1128/JVI.00088-16. Print 2016 May 15.

PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains

Affiliations

PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains

Eri Saijo et al. J Virol. .

Abstract

Understanding the structure of PrP(Sc) and its strain variation has been one of the major challenges in prion disease biology. To study the strain-dependent conformations of PrP(Sc), we purified proteinase-resistant PrP(Sc) (PrP(RES)) from mouse brains with three different murine-adapted scrapie strains (Chandler, 22L, and Me7) and systematically tested the accessibility of epitopes of a wide range of anti-PrP and anti-PrP(Sc) specific antibodies by indirect enzyme-linked immunosorbent assay (ELISA). We found that epitopes of most anti-PrP antibodies were hidden in the folded structure of PrP(RES), even though these epitopes are revealed with guanidine denaturation. However, reactivities to a PrP(Sc)-specific conformational C-terminal antibody showed significant differences among the three different prion strains. Our results provide evidence for strain-dependent conformational variation near the C termini of molecules within PrP(Sc) multimers.

Importance: It has long been apparent that prion strains can have different conformations near the N terminus of the PrP(Sc) protease-resistant core. Here, we show that a C-terminal conformational PrP(Sc)-specific antibody reacts differently to three murine-adapted scrapie strains. These results suggest, in turn, that conformational differences in the C terminus of PrP(Sc) also contribute to the phenotypic distinction between prion strains.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Epitopes of anti-PrP antibodies used in this study. The schematic representation of PrP primary structure (mouse residues 81 to 231) shows epitopes of anti-PrP antibodies. CHO indicate the N-linked glycosylation sites at residues 180 and 196 in PrP. A disulfide bond is indicated by S-S. Two β-sheets (β1 and β2) and three α-helices (α1, α2, and α3) exist in PrPC; however, the secondary structure of PrPC is not maintained in PrPSc. The C-terminal region is recognized by the PrPSc-specific MAb 6H10 (215 to 216, 221 to 223, and 228 [dark-blue arrows]) in PrPSc and the human Fab anti-PrP antibody R1 (224 to 230 [red arrow]) in both PrPC and PrPSc.
FIG 2
FIG 2
Epitopes of PrP antibodies with more N-terminal linear epitopes were largely hidden in the folded conformation of PrPRES. Purified PrPRES from wild-type mice inoculated with the Chandler strain and with the 22L strain were used to examine the epitope accessibilities of the indicated more N-terminal PrP antibodies using indirect ELISA. The linear epitopes are shown in parentheses. Each of the epitopes was much less accessible in the folded conformation than after treatments with chaotropic 3 or 8 M GdnHCl solutions. OD450 readings with background subtracted are indicated as the means and SD from triplicate wells. Similar results were obtained in at least three independent experiments.
FIG 3
FIG 3
Epitopes of PrP antibodies with linear epitopes near glycosylation sites were largely hidden in the folded conformation of PrPRES. Preparations of wild-type murine Chandler (dark blue) and 22L (light blue) PrPRES were either folded (untreated) or treated with 3 M or 8 M GdnHCl prior to indirect-ELISA measurements using the indicated primary anti-PrP antibodies, with epitopes shown in parentheses. OD450 readings with background subtracted are indicated as the means and SD from triplicate wells. Similar results were obtained in at least three independent experiments.
FIG 4
FIG 4
The PrPSc-specific C-terminal antibody 6H10 recognized the abnormal conformations of Me7 and 22L, but not Chandler, PrPRES. The OD450 readings of MAbs 132, SAF-70, 8H4, and 94B4 after 8 M GdnHCl treatment showed that approximately equivalent amounts of PrPRES were loaded into each well in ELISA plates. (A) MAb 132 was used to normalize the OD450 reading. (B) The same data were normalized to MAb 8H4 readings. Twofold dilutions of PrPRES were used to show that the OD450 readings were in a responsive range (the nine bars on the right in panels A and B). (C) Because PrPRES was treated with PK and several possible PK cleavage sites are at the C terminus of PrP, the C-terminal linear-epitope antibody R1 was used to examine whether the C-terminal epitopes were still present in PrPRES. OD450 readings with background subtracted are indicated as the means and SD from triplicate wells. *, P < 0.05; **, P < 0.01; ***, P < 0.005; one-way ANOVA followed by the FDR (Benjamini-Hochberg) test. Similar results were obtained in at least three independent experiments.
FIG 5
FIG 5
MAb 6H10 differed in its binding to the 22L and Chandler PrPRES lacking GPI anchors and N-linked glycosylations. Purified GPIneg Chandler and 22L PrPRES were tested for epitope exposure of 6H10 using indirect ELISA. The OD450 readings of MAbs 132, SAF-70, 8H4, and 94B4 after 8 M GdnHCl treatment showed that equivalent amounts of PrPRES were loaded in each well in the ELISA plates, and MAb 132 was used to normalize the OD450 readings. Twofold dilutions of PrPRES were used to show that the OD450 readings were in a responsive range. OD450 readings with background subtracted are indicated as the means and SD from triplicate wells. *, P < 0.05; **, P < 0.01; ***, P < 0.005; unpaired two-tailed Student's t test. Similar results were obtained in at least three independent experiments.

Similar articles

Cited by

References

    1. Prusiner SB. 1998. Prions. Proc Natl Acad Sci U S A 95:13363-13383. doi:10.1073/pnas.95.23.13363. - DOI - PMC - PubMed
    1. Caughey B. 2001. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 26:235–242. doi:10.1016/S0968-0004(01)01792-3. - DOI - PubMed
    1. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672–7680. doi:10.1021/bi00245a003. - DOI - PubMed
    1. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. 2005. The most infectious prion protein particles. Nature 437:257–261. doi:10.1038/nature03989. - DOI - PMC - PubMed
    1. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405. doi:10.1126/science.275.5298.402. - DOI - PubMed

Publication types

LinkOut - more resources